| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Comm. &Patient Officer
1 company
Besthof Robert is a Chief Comm. &Patient Officer at NRXP. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $279K at current prices.
Besthof Robert's largest disclosed position is in NRXP as Chief Comm. &Patient Officer, worth about $279K. The recent filings there lean toward selling, a net 40,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | NRXP Nrx Pharmaceuticals, Inc. | Chief Comm. &Patient Officer | Sale+OE | 40,000 | $11.76 | $470,400.00 | -62.8% | -52.4% | -93.2% |